Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06288191
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-02-04
Brief Title:
Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma
Sponsor:
Melanoma Institute Australia
Organization:
Melanoma Institute Australia
Organization Data
Organization:
Melanoma Institute Australia
Class:
OTHER
Study ID:
MIA2023490
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Melanoma Institute Australia
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |